SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Dec 27, 2019
Document Date
Dec 27, 2019
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.